<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02246153</url>
  </required_header>
  <id_info>
    <org_study_id>NFEC-2014-067</org_study_id>
    <nct_id>NCT02246153</nct_id>
  </id_info>
  <brief_title>Laparoscopy-assisted and Open Distal Gastrectomy for Gastric Cancer in the Elderly Patients</brief_title>
  <official_title>Morbidity and Mortality of Laparoscopy-assisted and Open Distal Gastrectomy for Gastric Cancer in the Elderly Patients: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanfang Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanfang Hospital of Southern Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer (EGC)&#xD;
           has been supported by high-quality evidence, and the high-level evidence for advanced&#xD;
           gastric cancer based on large prospective randomized controlled trial as CLASS-01„ÄÅJCOG&#xD;
           0901, KLASS -02 is still awaited.Hopefully, it would have also gained the solid evidence&#xD;
           of laparoscopy-assisted distal gastrectomy for the treatment of advanced gastric cancer&#xD;
           (AGC).&#xD;
&#xD;
        -  China has entered the aging society since 1999. Among the GC patients in China, the&#xD;
           average age is 65 years old, which makes increasing attempts to explore laparoscopic&#xD;
           techniques in the treatment of elderly patients.&#xD;
&#xD;
        -  Nowadays, a considerable proportion of elderly patients suffer from multiple diseases,&#xD;
           such as hypertension, diabetes, coronary heart disease. Thus the risk of intraoperative&#xD;
           and postoperative complications can not be ignored. Unfortunately, there are rare&#xD;
           studies specializing into the LAG for the GC patients of &gt; 65 years old.&#xD;
&#xD;
        -  Accordingly, the comparison of intraoperative and postoperative complications between&#xD;
           laparoscopy-assisted and open distal gastrectomy for over 65 years old patients with&#xD;
           gastric cancer based on a randomized controlled trial is warranted.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative complication rate</measure>
    <time_frame>30 days</time_frame>
    <description>30 day morbidity and mortality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pulmonary complications</measure>
    <time_frame>30 days</time_frame>
    <description>Pulmonary complications after operation within 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative recovery index</measure>
    <time_frame>7 days</time_frame>
    <description>participants will be followed for the duration of hospital stay after operation, an expected average of 7 days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">202</enrollment>
  <condition>Complications</condition>
  <arm_group>
    <arm_group_label>Laparoscopic gastrectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopy-assisted distal gastrectomy with D2 lymphadenectomy will be performed for the treatment of patients assigned to this group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open gastrectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Open distal gastrectomy with D2 lymphadenectomy will be performed for the treatment of patients assigned to this group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic gastrectomy</intervention_name>
    <description>After exclusion of T4b, bulky lymph nodes, or distant metastasis case by diagnostic laparoscopy, laparoscopic distal subtotal gastrectomy and D2 lymph node dissection will be performed with curative treated intent.&#xD;
The type of reconstruction will be selected according to the surgeon's experience and anastomotic procedure is performed extracorporeally using a mini-laparotomy.</description>
    <arm_group_label>Laparoscopic gastrectomy</arm_group_label>
    <other_name>LDG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open gastrectomy</intervention_name>
    <description>After exclusion of T4b, bulky lymph nodes, or distant metastasis case by diagnostic laparoscopy, open distal subtotal gastrectomy and D2 lymph node dissection will be performed with curative treated intent.&#xD;
The type of reconstruction will be selected according to the surgeon's experience.</description>
    <arm_group_label>Open gastrectomy</arm_group_label>
    <other_name>ODG</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age over 65 years&#xD;
&#xD;
          -  Primary gastric adenocarcinoma (papillary, tubular, mucinous, signet ring cell, or&#xD;
             poorly differentiated) confirmed pathologically by endoscopic biopsy&#xD;
&#xD;
          -  cT1-4a, N0-3, M0 at preoperative evaluation according to the AJCC Cancer Staging&#xD;
             Manual Seventh Edition&#xD;
&#xD;
          -  Expected curative resection through distal subtotal gastrectomy with D2&#xD;
             lymphadenectomy&#xD;
&#xD;
          -  Performance status of 0 or 1 on ECOG (Eastern Cooperative Oncology Group) scale&#xD;
&#xD;
          -  ASA (American Society of Anesthesiology) score class I, II, or III&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe mental disorder&#xD;
&#xD;
          -  History of previous upper abdominal surgery (except laparoscopic cholecystectomy)&#xD;
&#xD;
          -  History of previous gastrectomy, endoscopic mucosal resection or endoscopic submucosal&#xD;
             dissection&#xD;
&#xD;
          -  Exclude the early gastric cancer feasible for ESD&#xD;
&#xD;
          -  Enlarged or bulky regional lymph node diameter over 3cm by preoperative imaging&#xD;
&#xD;
          -  History of other malignant disease within past five years&#xD;
&#xD;
          -  History of previous neoadjuvant chemotherapy or radiotherapy&#xD;
&#xD;
          -  History of unstable angina or myocardial infarction within past six months&#xD;
&#xD;
          -  History of cerebrovascular accident within past six months&#xD;
&#xD;
          -  History of continuous systematic administration of corticosteroids within one month&#xD;
&#xD;
          -  Requirement of simultaneous surgery for other disease&#xD;
&#xD;
          -  Emergency surgery due to complication (bleeding, obstruction or perforation) caused by&#xD;
             gastric cancer&#xD;
&#xD;
          -  FEV1&lt;50% of predicted values&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guoxin Li, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nanfang Hospital of Southern Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guoxin Li, M.D., Ph.D.</last_name>
    <phone>+86-138-0277-1450</phone>
    <email>gzliguoxin@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hao Liu, M.D., PhD</last_name>
    <phone>+86-138-2215-8578</phone>
    <email>liuhaofbi@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nanfang Hospital, Southern Medical University</name>
      <address>
        <city>Guangzhou</city>
        <zip>510515</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guoxin Li, M.D., Ph.D.</last_name>
      <phone>+86-138-0277-1450</phone>
      <email>gzliguoxin@163.com</email>
    </contact>
    <investigator>
      <last_name>Guoxin Li, M.D.,Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jiang Yu, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yanfeng Hu, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tingyu Mou, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hao Liu, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.fimmu.com/index_com.html</url>
    <description>Southern Medical University, China</description>
  </link>
  <link>
    <url>http://www.nfyy.com/</url>
    <description>Nanfang Hospital, China</description>
  </link>
  <link>
    <url>http://www.caca.org.cn/</url>
    <description>Chinese Anti-Cancer Association</description>
  </link>
  <reference>
    <citation>Yu J, Hu J, Huang C, Ying M, Peng X, Wei H, Jiang Z, Du X, Liu Z, Liu H, Li G; Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group. The impact of age and comorbidity on postoperative complications in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: results from the Chinese laparoscropic gastrointestinal surgery study (CLASS) group. Eur J Surg Oncol. 2013 Oct;39(10):1144-9. doi: 10.1016/j.ejso.2013.06.021. Epub 2013 Jul 10.</citation>
    <PMID>23850088</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <study_first_submitted>September 15, 2014</study_first_submitted>
  <study_first_submitted_qc>September 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2014</study_first_posted>
  <last_update_submitted>January 7, 2017</last_update_submitted>
  <last_update_submitted_qc>January 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nanfang Hospital of Southern Medical University</investigator_affiliation>
    <investigator_full_name>Guoxin Li</investigator_full_name>
    <investigator_title>M.D.,Ph.D., F.R.C.S.</investigator_title>
  </responsible_party>
  <keyword>Laparoscopic gastrectomy</keyword>
  <keyword>Advanced gastric cancer</keyword>
  <keyword>Elderly patients</keyword>
  <keyword>Morbidity</keyword>
  <keyword>Mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

